Skip to Content

'
Wayne L. Hofstetter, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Esophageal Surgery Program, Department of Thoracic and Cardiovascular Surgery - Research, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Wayne L. Hofstetter, M.D., is currently Associate Professor in the Department of Thoracic and Cardiovascular Surgery and serves as Director of the Esophageal Surgery Program.

A graduate of the University of Southern California Medical School, Dr. Hofstetter focused on thoracic surgical disease, completing fellowships in esophageal and foregut surgeries at the University of Southern California, and then thoracic oncology at M. D. Anderson Cancer Center. Broadly trained as a cardiothoracic surgeon and thoracic oncologist at the Texas Heart Institute, he now devotes a great deal of his work to esophageal cancer and lung cancer. At M. D. Anderson, he formed a strong network of clinicians with specific interests in esophageal diseases. A multidisciplinary group emerged under his able leadership, and together, physicians from other specialties like Gastrointestinal Medical Oncology, Radiation Oncology, and Gastroenterology collaborate closely to treat esophageal cancer patients.

Dr. Hofstetter is a leading proponent of surgical and multidisciplinary approaches to esophageal cancer and minimally invasive approaches to lung cancer, bringing to the institution his unique clinical skills in MIS approaches to thoracic surgery.

Board certified both by the American Board of Surgery and the American Board of Thoracic Surgery, Dr. Hofstetter is nationally and internationally involved in a host of clinical and scientific endeavors with membership in several organizations, including the American Society of Clinical Oncology, the Society of Thoracic Surgeons, and the International Association for the Study of Lung Cancer. His research, which forms a vital part of his academic role, has led to numerous peer-reviewed publications, notably in such journals as the Journal of Thoracic and Cardiovascular Surgery, Annals of Surgery, and Cancer.

Office Address

Fax: (713) 794-4901

Education & Training

Degree-Granting Education

1993 University of Southern California Medical School, Los Angeles, CA, MD, MD
1989 University of California at Davis, Davis, CA, BA, Economics

Postgraduate Training

1/2002-6/2002 Fellow, Cardiovascular Surgery, Texas Heart Institute, Houston, TX, David Ott, M.D.
1/2001-12/2001 Fellow, Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, Jack A. Roth, M.D.
7/2000-12/2000 Fellow, Cardiovascular Surgery, Texas Heart Institute, Houston, TX, David Ott, M.D.
7/1999-6/2000 Fellow, Thoracic and Esophageal, USC University Hospital, Los Angeles, CA, Tom DeMeester, M.D.
7/1996-7/1997 Research Fellowship, LAC+USC, Department of Surgery,, Los Angeles, CA, Robert Beart, M.D.
7/1994-6/1999 Resident, General Surgery, General Surgery LAC+USC Medical Center/USC University Hospital, Kenneth J. Norris Cancer Center, Los Angeles, CA, Gary L. Dunnington, M.D and Fred A. Weaver, M.D.
6/1993-6/1994 Intern, Surgery, The Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, CA, Gary L. Dunnington, M.D

Board Certifications

1/2002 American Board of Thoracic Surgery
1/2000 American Board of Surgery

Experience/Service

Academic Appointments

Assistant Professor, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1/2004-8/2007
Assistant Professor, Departments of Thoracic Surgery and Surgical Oncology, David Geffen UCLA School of Medicine, Los Angeles, CA, 8/2002-8/2004
Instructor, LAC+USC County Hospital, Los Angeles, CA, 7/1999-6/2000
Junior Faculty, Kenneth Norris Jr. Cancer Center and USC University Hospital, Los Angeles, CA, 7/1999-6/2000

Institutional Committee Activities

Member, Credential Committee of the Medical Staff, 9/2010-present
Member, Faculty Sentate, 9/2009-present
Member, VAT Committee, 2009-present
Member, Medical Practice Subcommittee, 1/2005-2008
Director, Esophageal Tumor Board, 1/2004-present

Honors and Awards

2011 Dwight C. McGoon Award, Thoracic Surgery Resident's Association (TSRA)
2010 Dwight C. McGoon Award, Thoracic Surgery Residents Association (TSRA)
2006 The Surgery Chief Resident Teaching Award, The University of Texas Houston Medical School, Department of Surgery
2005 Robert Ginsberg Surgical Oncology Award, The Radiation Therapy Oncology Group

Professional Memberships

Alpha Omega Alpha Honor Medical Society
Member, 4/2012-present
American Association for Thoracic Surgery
Member, 1/2005-present
American Society of Clinical Oncology
Active member, 4/2009-present
Cooley Hands, Houston, TX
Member, 2008-present
Credentials Committee of the Medical Staff
Member, 11/2010-present
General Thoracic Surgical Club
Member, 2/2005-present
Harris County Medical Society, TX
Member, 7/2007-present
International Association for the Study of Lung Cancer
Member, 3/2005-present
MDACC Faculty Senate
Member, 2012-present
NCCN Esophagus, Fort Washington, PA
Member, 2009-present
Society of Graduate Surgeons of the Los Angeles County/University of Southern California Medical Center, Los Angeles, CA
Member, 2000-present
Society of Thoracic Surgeons
Member, 1/2007-present
Southern Thoracic Surgical Association
Member, 1/2004-present
Southwest Oncology Group
Member, 7/2007-present
Texas Medical Association, TX
Member, 7/2007-present
The American Board of Surgery
Member, 2/2000-present
The American Board of Thoracic Surgery
Member, 6/2003-present
The Society of Surgery of the Alimentary Tract
Member, 2/2013-present
Value Analysis Team (VAT)
Product/Service Evaluator, 9/2012-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer 48(18):3396-404, 12/2012. e-Pub 7/2012. PMID: 22853875.
2. Hofstetter, WL. "Current and Future Options for Treating Esophageal Cancer: A Paradigm Shift Toward Organ-Sparing Therapies". Texas Heart Institute Journal(Ms. No. THIJ-12-2841), 12/2012.
3. Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg 94(6):1802-9, 12/2012. e-Pub 10/2012. PMID: 23063195.
4. Lin SH, Wang L, Myles B, Thall PF, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z. Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer. Int J Radiat Oncol Biol Phys 84(5):1078-85, 12/2012. e-Pub 8/2012. PMID: 22867894.
5. Balani D, Aeberli D, Hofstetter W, Seitz M. IL-17A stimulates GM-CSF release in the presence of 1,25(OH)(2) D(3) by osteoblasts and inhibits osteoclast development in vitro. Arthritis Rheum. e-Pub 11/2012. PMID: 23124514.
6. Braun T, Lepper J, Heiland GR, Hofstetter W, Siegrist M, Lezuo P, Gaestel M, Rumpler M, Thaler R, Klaushofer K, Distler JH, Schett G, Zwerina J. Mitogen- activated protein kinase 2 (MK2) regulates physiological and pathological bone turnover. J Bone Miner Res. e-Pub 11/2012. PMID: 23169443.
7. Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WL. Omental reinforcement of the thoracic esophagogastric anastomosis: An analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg 144(5):1146-51, 11/2012. e-Pub 8/2012. PMID: 22939861.
8. Thosani N, Lee JH, Hofstetter WL, Ajani JA, Guha S, Bhutani MS. Response. Gastrointest Endosc 76(5):1073-5, 11/2012. PMID: 23078931.
9. Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol. e-Pub 7/2012. PMID: 22831985.
10. Amini A, Xiao L, Allen PK, Suzuki A, Hayashi Y, Liao Z, Hofstetter W, Crane C, Komaki R, Bhutani MS, Lee JH, Ajani JA, Welsh J. Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys 83(2):e231-9, 6/2012. e-Pub 3/2012. PMID: 22436793.
11. Hofstetter WL. Lymphadenectomy as a benchmark to surgical quality in esophagectomy: comment on "variation in lymph node examination after esophagectomy for cancer in the United States". Arch Surg 147(6):511-2, 6/2012. PMID: 22786537.
12. Welsh J, Settle SH, Amini A, Xiao L, Suzuki A, Hayashi Y, Hofstetter W, Komaki R, Liao Z, Ajani JA. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer 118(10):2632-40, 5/2012. e-Pub 10/2011. PMID: 22565611.
13. Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PW, Lee JE, Rice DC, Hofstetter WL, Wolff RA, Varadhachary GR, Wang H, Katz MH. Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection. J Gastrointest Surg. e-Pub 5/2012. PMID: 22644446.
14. Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JD. Proton Beam Therapy and Concurrent Chemotherapy for Esophageal Cancer. Int J Radiat Oncol Biol Phys. e-Pub 3/2012. PMID: 22417808.
15. Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 143(2):412-20, 2/2012. e-Pub 12/2011. PMID: 22172216.
16. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for Prognostication of Outcome in Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy. Oncology 82(2). e-Pub 2/2012. PMID: 22328056.
17. Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki R. Esophageal Cancer Dose Escalation using a Simultaneous Integrated Boost Technique. Int J Radiat Oncol Biol Phys 82(1):468-74, 1/2012. e-Pub 12/2010. PMID: 21123005.
18. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus. e-Pub 12/2011. PMID: 22150920.
19. Thosani N, Singh H, Kapadia A, Ochi N, Lee JH, Ajani J, Swisher SG, Hofstetter WL, Guha S, Bhutani MS. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. Gastrointest Endosc. e-Pub 11/2011. PMID: 22115605.
20. Kim JY, Hanasono MM, Fleming JB, Berry MD, Hofstetter WL. Combined Esophagectomy and Pancreaticoduodenectomy: Expanded Indication for Supercharged Jejunal Interposition. J Gastrointest Surg 15(10):1893-5, 10/2011. e-Pub 5/2011. PMID: 21541769.
21. Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL. Does the Timing of Esophagectomy After Chemoradiation Affect Outcome? Ann Thorac Surg. e-Pub 9/2011. PMID: 21962263.
22. Hofstetter WL. Invited commentary. Patterns of Lymph Node Metastasis and Survival for Upper Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 92(3):1097-8, 9/2011. PMID: 21871305.
23. Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, National Comprehensive Cancer Network. Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw 9(8):830-87, 8/2011. PMID: 21900218.
24. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6(7):1274-81, 7/2011. PMID: 21623235.
25. Estrella JS, Hofstetter WL, Correa AM, Swisher SG, Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DM. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am J Surg Pathol 35(7):1045-53, 7/2011. PMID: 21602659.
26. Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg 212(5):821-6, 5/2011. e-Pub 3/2011. PMID: 21435923.
27. Swisher SG, Winter KA, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. A Phase II Study of a Paclitaxel Based Chemoradiation Regimen with Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246. Int J Radiat Oncol Biol Phys. e-Pub 4/2011. PMID: 21507583.
28. Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity-Modulated Proton Therapy Further Reduces Normal Tissue Exposure During Definitive Therapy for Locally Advanced Distal Esophageal Tumors: A Dosimetric Study. Int J Radiat Oncol Biol Phys. e-Pub 4/2011. PMID: 21470796.
29. Mehran R, Rice D, El-Zein R, Huang JL, Vaporciyan A, Goodyear A, Mehta A, Correa A, Walsh G, Roth J, Swisher S, Hofstetter W. Minimally invasive esophagectomy versus open esophagectomy, a symptom assessment study. Dis Esophagus 24(3):147-52, 4/2011. e-Pub 10/2010. PMID: 21040152.
30. Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I, Hofstetter WL, Putnam JB, Vaporciyan AA. Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial. J Clin Oncol 29(8):994-1000, 3/2011. e-Pub 1/2011. PMCID: PMC3068055.
31. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience. Cancer 117(5):925-30, 3/2011. e-Pub 10/2010. PMCID: PMC3080168.
32. Suzuki A, Xiao L, Hayashi Y, Macapinlac HA, Welsh J, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Swisher SG, Ajani JA. Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer. e-Pub 3/2011. PMCID: PMC3144261.
33. Welsh J, Amini A, Likhacheva A, Erasmus J J, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee H J, Bhutani MS, Ajani JA. Update: Modern Approaches to the Treatment of Localized Esophageal Cancer. Curr Oncol Rep. e-Pub 3/2011. PMID: 21365188.
34. Mendelson J, Song S, Li Y, Maru DM, Mishra B, Davila M, Hofstetter WL, Mishra L. Dysfunctional transforming growth factor-ß signaling with constitutively active notch signaling in Barrett's esophageal Adenocarcinoma. Cancer. e-Pub 2/2011. PMID: 21305538.
35. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, Members of the M. D. Anderson Esophageal Cancer Group and the University of Rochester School of Medicine and Dentistry Foregut Group. Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer 117(1):63-9, 1/2011. e-Pub 8/2010. PMID: 20803613.
36. He Y, Correa AM, Raso MG, Hofstetter WL, Fang B, Behrens C, Roth JA, Zhou Y, Yu L, Wistuba II, Swisher SG, Pataer A. The Role of PKR/eIF2a Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer. PLoS One 6(11):e24855, 2011. e-Pub 11/2011. PMCID: PMC3213082.
37. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 116(24):5619-27, 12/2010. e-Pub 11/2010. PMID: 21136578.
38. Vallböhmer D, Hölscher AH, DeMeester S, DeMeester T, Salo J, Peters J, Lerut T, Swisher SG, Schröder W, Bollschweiler E, Hofstetter W. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg 252(5):744-9, 11/2010. PMID: 21037429.
39. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Members of the MD Anderson Esophageal Cancer Group, the University of Rochester School of Medicine, Dentistry Foregut Group. A Clinical Nomogram Predicting Pathologic Lymph Node Involvement in Esophageal Cancer Patients. Ann Surg 252(4):611-617, 10/2010. PMID: 20881767.
40. Patnana SV, Murthy SB, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography. Cancer(116(19)):4487-94, 10/2010. e-Pub 7/2010. PMID: 20629031.
41. Gu J, Ajani JA, Hawk E, Ye Y, Lee JH, Bhutani M, Hofstetter WL, Swisher SG, Wang KK, Wu X. Chromosomal Aberrations Predict Malignant Progression of Esophageal Adenocarcinoma: a Genome-wide High-Density SNP Array Analysis. Cancer Prev Res (Phila Pa) 3(9):1176-86, 9/2010. e-Pub 7/2010. PMID: 20651033.
42. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved Long-term Outcome with Chemoradiotherapy Strategies in Esophageal Cancer. Ann Thorac Surg 90(3):892-8; discussion 898-9, 9/2010. PMID: 20732514.
43. Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status. Ann Thorac Surg 90(3):884-90; discussion 890-1, 9/2010. PMID: 20732513.
44. Murthy SB, Patnana SV, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinalac HA, Wang X, Ajani JA. The Standardized Uptake Value of 18-Fluorodeoxyglucose Positron Emission Tomography after Chemoradiation and Clinical Outcome in Patients with Localized Gastroesophageal Carcinoma. Oncology 78(5-6). e-Pub 8/2010. PMID: 20699623.
45. Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran C, Vaporciyan AA, Roth JA. Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg 90(1):210-6, 7/2010. PMID: 20609777.
46. Gaur P, Hofstetter WL, Bekele BN, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SG. Comparison Between Established and the Worldwide Esophageal Cancer Collaboration Staging Systems. Ann Thorac Surg 89(6):1797-1803; discussion 1803-4, 6/2010. PMID: 20494031.
47. Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G. Gastric cancer. J Natl Compr Canc Netw 8(4):378-409, 4/2010. PMID: 20410333.
48. Zhou Y, Hofstetter WL, He Y, Hu W, Pataer A, Wang L, Wang J, Zhou Y, Yu L, Fang B, Swisher SG. KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Cancer Biol Ther 9(7). e-Pub 4/2010. PMID: 20215880.
49. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 4/2010. PMID: 20143431.
50. Bose D, Meric-Bernstam F, Hofstetter W, Reardon DA, Flaherty KT, Ellis LM. Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. Lancet Oncol 11(4):373-82, 4/2010. e-Pub 2/18/2010. PMID: 20171141.
51. Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Hofstetter WL, Watson TJ, Allen MS, Rusch VW, Blackstone EH. Optimum lymphadenectomy for esophageal cancer. Ann Surg 251(1):46-50, 1/2010. PMID: 20032718.
52. Goodarzi M, Correa AM, Ajani JA, Swisher SG, Hofstetter WL, Guha S, Deavers MT, Rashid A, Maru DM. Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Mod Pathol 22(12):1612-21, 12/2009. e-Pub 9/2009. PMID: 19734842.
53. Javeri H, Xiao L, Rohren E, Lee JH, Liao Z, Hofstetter W, Maru D, Bhutani MS, Swisher SG, Macapinlac H, Wang X, Ajani JA. The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma. Cancer 115(22):5184-92, 11/2009. e-Pub 8/2009. PMID: 19685531.
54. Kim MP, Hofstetter WL. Tumors of the diaphragm. Thorac Surg Clin 19(4):521-9, 11/2009. PMID: 20112635.
55. Braiteh F, Correa AM, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Ajani JA. Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy. Cancer 115(19):4450-4458, 10/2009. e-Pub 6/2009. PMID: 19562780.
56. Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 138(4):831-6, 10/2009. e-Pub 4/2009. PMID: 19660349.
57. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, Hofstetter WL, Marom EM, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG. Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg 88(3):862-8; discussion 868-9, 9/2009. PMID: 19699913.
58. Hu W, Hofstetter WL, Li H, Zhou Y, He Y, Pataer A, Wang L, Xie K, Swisher SG, Fang B. Putative tumor-suppressive function of kruppel-like factor 4 in primary lung carcinoma. Clin Cancer Res 15(18):5688-95, 9/2009. e-Pub 9/2009. PMCID: PMC2745510.
59. Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG, Mehran R. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 88(3):877-84; discussion 884-5, 9/2009. PMID: 19699915.
60. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418.e1-2, 8/2009. e-Pub 5/2009. PMCID: PMC2731793.
61. Bolton WD, Rice DC, Correa AM, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer. Am Surg 75(7):598-603; discussion 603-4, 7/2009. PMID: 19655604.
62. Zhang Z, Chen Y, Chen Y, Jeter M, Hofstetter WL, Ajani J, Swisher SG, Chang JY, Allen PK, Cox JD, Komaki R, Liao ZX. Outcomes with esophageal cancer radiation therapy. J Thorac Oncol 4(7):880-8, 7/2009. PMID: 19458557.
63. Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JD. Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort. Int J Radiat Oncol Biol Phys 74(2):482-9, 6/2009. e-Pub 3/2009. PMID: 19289262.
64. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-87, 6/2009. PMID: 19464452.
65. Fernando HC, Murthy SC, Hofstetter W, Shrager JB, Bridges C, Mitchell JD, Landreneau RJ, Clough ER, Watson TJ. The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia. Ann Thorac Surg 87(6):1993-2002, 6/2009. PMID: 19463651.
66. Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra R. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol 174(5):1940-8, 5/2009. e-Pub 3/2009. PMCID: PMC2671281.
67. Callender GG, Grubbs EG, Vu T, Hofstetter WL, Fleming JB, Woodburn KL, Lee JE, Evans DB, Perrier ND. The fallen one: the inferior parathyroid gland that descends into the mediastinum. J Am Coll Surg 208(5):887-93; discussion 893-5, 5/2009. PMID: 19476855.
68. Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid A. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival. Cancer 115(7):1576-85, 4/2009. PMID: 19156915.
69. Hu W, Hofstetter W, Wei X, Guo W, Zhou Y, Pataer A, Li H, Fang B, Swisher SG. Double-stranded RNA-dependent protein kinase-dependent apoptosis induction by a novel small compound. J Pharmacol Exp Ther 328(3):866-72, 3/2009. e-Pub 12/2008. PMCID: PMC2658620.
70. Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, Maru D, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA. Esophageal tumor length is independently associated with long-term survival. Cancer 115(3):508-16, 2/2009. PMID: 19117343.
71. Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JA. Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer 115(3):624-30, 2/2009. PMID: 19130466.
72. Cen P, Correa AM, Lee JH, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009. e-Pub 11/2008. PMID: 19021684.
73. Izzo JG, Wu X, Wu TT, Huang P, Lee JS, Liao Z, Lee JH, Bhutani MS, Hofstetter W, Maru D, Hung MC, Ajani JA. Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation. Dis Esophagus 22(2):127-32, 2009. e-Pub 11/2008. PMID: 19021681.
74. Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RL. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol 3(9):979-84, 9/2008. PMID: 18758299.
75. Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Liao Z, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani JA. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. Cancer 113(6):1302-8, 9/2008. PMID: 18623381.
76. Hu W, Hofstetter W, Guo W, Li H, Pataer A, Peng HH, Guo ZS, Bartlett DL, Lin A, Swisher SG, Fang B. JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase. Cancer Gene Ther 15(9):616-24, 9/2008. e-Pub 6/2008. PMCID: PMC2553758.
77. Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32(9):1404-11, 9/2008. PMID: 18670347.
78. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer 112(5):1020-7, 3/2008. PMID: 18205187.
79. Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma. Cancer 112(3):503-10, 2/2008. PMID: 18072264.
80. Yendamuri S, Komaki RR, Correa AM, Allen P, Wynn B, Blackmon S, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol 2(11):1022-8, 11/2007. PMID: 17975494.
81. Abraham SC, Krasinskas AM, Correa AM, Hofstetter WL, Ajani JA, Swisher SG, Wu TT. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol 31(11):1719-25, 11/2007. PMID: 18059229.
82. Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84(5):1685-92; discussion 1692-3, 11/2007. PMID: 17954086.
83. Abraham SC, Krasinskas AM, Hofstetter WL, Swisher SG, Wu TT. "Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. Am J Surg Pathol 31(11):1629-35, 11/2007. PMID: 18059218.
84. Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, Liao Z, Maru D, Wu TT, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Francis A, Blackmon S, Swisher SG. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84(2):365-73; discussion 374-5, 8/2007. PMID: 17643602.
85. Izzo JG, Malhotra U, Wu TT, Luthra R, Correa AM, Swisher SG, Hofstetter W, Chao KS, Hung MC, Ajani JA. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression. Cancer Epidemiol Biomarkers Prev 16(6):1200-5, 6/2007. PMID: 17548685.
86. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer 109(4):658-67, 2/2007. PMID: 17211865.
87. Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109(1):125-34, 1/2007. PMID: 17146785.
88. Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol 31(1):58-64, 1/2007. PMID: 17197919.
89. Swisher SG, Hofstetter WL, Miller MJ. The supercharged microvascular jejunal interposition. Semin Thorac Cardiovasc Surg 19(1):56-65, 2007. PMID: 17403459.
90. Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients. Ann Thorac Surg 82(6):1982-7; discussion 1987-8, 12/2006. PMID: 17126095.
91. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 107(5):967-974, 9/2006. PMID: 16874819.
92. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12(15):4598-604, 8/2006. PMID: 16899607.
93. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol 1(5):478-86, 6/2006. PMID: 17409902.
94. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106(5):1017-25, 3/2006. PMID: 16456809.
95. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 1/2006. e-Pub 12/2005. PMID: 16399296.
96. Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 80(6):1988-92; discussion 1992-3, 12/2005. PMID: 16305830.
97. Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg 130(6):1601-10, 12/2005. PMID: 16308005.
98. Martin LW, Swisher SG, Hofstetter W, Correa AM, Mehran RJ, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg 242(3):392-9; discussion 399-402, 9/2005. PMCID: PMC1357747.
99. Liu L, Hofstetter WL, Rashid A, Swisher SG, Correa AM, Ajani JA, Hamilton SR, Wu TT. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 29(8):1079-85, 8/2005. PMID: 16006804.
100. Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241(5):810-7; discussion 817-20, 5/2005. PMCID: PMC1357136.
101. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Treatment outcomes of resected esophageal cancer. Ann Surg 236(3):376-84; discussion 384-5, 9/2002. PMCID: PMC1422591.
102. Hofstetter WL, Peters JH, DeMeester TR, Hagen JA, DeMeester SR, Crookes PF, Tsai P, Banki F, Bremner CG. Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg 234(4):532-8; discussion 538-9, 10/2001. PMCID: PMC1422076.
103. Hofstetter W, Ortega A, Chiang M, Brown B, Paik P, Youn P, Beart RW. Abdominal insufflation does not cause hematogenous spread of colon cancer. J Laparoendosc Adv Surg Tech A 10(1):1-4, 2/2000. PMID: 10706295.
104. Hofstetter WL, Vukasin P, Ortega AE, Anthone G, Beart RW. New technique for mesh repair of paracolostomy hernias. Dis Colon Rectum 41(8):1054-5, 8/1998. PMID: 9715164.
105. Coburn WM, Russell MA, Hofstetter WL. Sucrose as an aid to manual reduction of incarcerated rectal prolapse. Ann Emerg Med 30(3):347-9, 9/1997. PMID: 9287900.
106. Raboff W, Calobrace MB, Anthony G, Garner D, Greenwald D, Brant A, Hopkins B, Soonthon V, Noonan T, Hofstetter W. Mesh reinforcement increases bursting strength of intestinal anastomoses in steroid-treated rabbits. Am Surg 60(10):721-7, 10/1994. PMID: 7944031.
107. Yong He1, Zhen Zhou, Wayne L. Hofstetter, Yanbin Zhou, Wenxian Hu, Chengcheng Guo, Li Wang, Wei Guo, Apar Pataer, Arlene M. Correa, Yiling Lu, Jing Wang, Lixia Diao, Lauren Averett Byers, Ignacio I. Wistuba, Jack A. Roth, Stephen G. Swisher , John V. Heymach and Bingliang Fang. Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Primary Lung Cancer and Their Association with Clinical Parameters. PLoS One. Submitted.
108. Schier R, Mehran R, El-Zein R, Varporciyan A, Hofstetter W, Correa AM, Aguilar J, Swafford J, Riedel B. Preoperative Microvascular Dysfunction: Expanding Risk Assessment Strategies in Major Non-Cardiovascular Surgery. Anesthesiology. Submitted.

Invited Articles
1. Hofstetter W. Invited commentary. Esophageal Leaks Repaired by Muscle Flaps. Ann Thorac Surg 88(3):973, 9/2009. PMID: 19699930.
2. Leung KK, Maru D, Abraham S, Hofstetter WL, Mehran R, Anandasabapathy S. Optical EMR: confocal endomicroscopy-targeted EMR of focal high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 69(1):170-2, 1/2009. e-Pub 6/2008. PMID: 18582880.
3. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest 134(6):1349; author reply 1350, 12/2008. PMID: 19059972.
4. Martin LW, Hofstetter W, Swisher SG, Roth JA. Management of intrathoracic leaks following esophagectomy. Adv Surg 40:173-190, 2006. PMID: 17163101.
5. Hofstetter , WL. Diagnostic Advantages of EMR for Gastroesophageal Cancers. Gastrointestinal Medicine Oncology. Submitted.

Editorials
1. Hofstetter WL. Invited commentary. Ann Thorac Surg 93(5):1681, 5/2012. PMID: 22541197.
2. Bhutani MS and Hofstetter WL. Transesophageal EUS and EUS-FNA for lung cancer. Where do we go from here? J Clin Gastroenterol 41(7):644-646, 8/2007. PMID: 17667046.

Abstracts
1. Skinner HD, Xu E, Lee JH, Bhutani MS, Weston B, Suzuki A, Hofstetter WL, Komaki R, Ajani JA, Wu X. A validated miRNA expression profile for response to neoadjuvant therapy in esophageal cancer. 2013 ASCO Annual Meeting(Abstract #112087), 5/2013.
2. Komaki R, Ajani JA, Hofstetter WL, Moughan J, Tsungteh WU, Akonski W, Willett C. "Final Results of RTOG 0246: A Phase II Study of Selective Surgical Resection for Locoreginally Advanced Esophageal Cancer Treated with a Paclitaxel Based Chemoradiation Regimen". ASCO 2013 GI Cancer Symposium, 2013.
3. Boris Sepesi, Arlene M. Correa, Abujiang Pataer, Neda Kalhor, Jeremy J. Erasmus, Wayne L. Hofstetter, Edward Kim, Ritsuko Komaki, Scott Lippman, Reza Mehran, Cesar A. Moran, David C. Rice, Jack A. Roth, Ara A. Vaporciyan, Garrett L. Walsh, William William, Ignacio Wistuba, Stephen G. Swisher. Impact of Histopathologic Response on Pathologic TNM Lung Cancer Staging System (AJCC 7th) Following Neoadjuvant Chemotherapy, 4/2012.
4. R.M. Thomas, M.J. Truty, J.B. Fleming, P.W. Pisters, J.E. Lee, D.C. Rice, W.L. Hofstetter, R.A.Wolff, G.R. Varadhachary, H.Wang, M.H. Katz. Selective Re-Operation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection, 3/2012.
5. Marom EM, Moran CA, Piu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed Tomography Findings Predicting Invasiveness of Thymoma. 40th Congress of the International Society of Oncology and Biomarkers, October 13-17, 2012; Jerusalem, Israel. 2012.
6. Atin Agarwal MD1, Taylor Appelberry1, Sushovan Guha MD, Ph.D1, Jaffer Ajani MD1, Wayne Hofstetter MD1, Stephen Swisher MD1, Patrick Lennon, Asif Rashid MD,Ph.D1 and Dipen Maru MD1. Novel chromosomal abnormalities in barrett's esophagus and esophageal adenocarcinoma identified by array comparative genomic hybridization of carefully macrodissected tissue, 2012.
7. Campagna MC, Taketa T, Correa AM, Sudo K,. Relapse In Patients with Esophageal and Esophagogastric junction (E-EGH) Cancer is Highly Associated with Surgical Stage after Trimodality Therapy (TMT): Implications for Customized Surveillance. GI ASCO 2012 for the E-EGJ Research Group at the Univeristy of Texas MD Anderson Cancer Center, Houston, Texas, 2012.
8. Jeannelyn S Estrella, Wayne Hofstetter, Arlene M Correa, Jaffer Ajani, Stephen Swisher, Asif Rashid, Dipen Maru. Measurement of Depth of Invasion, Submucosal and Lymphovascular Invasion (LVI) Predicts Lymph Node (LN) Involvement in T1 Esophageal Adenocarcinoma (EAC). Invasion of Duplicated Muscularis Mucosae (MM) Has Similar Risk of LN Involvement as Mucosal Invasion. United States and Canadian Academy of Pathology 2011, 3/2011.
9. Mahmoud Goodarzi, Rujuta Kanhere, Lynda Corley, Arlene Correa, Jaffer Ajani, Stephen Swisher, Wayne Hofstetter, Asif Rashid, Dipen Maru. Sox-9 Immunohistochemistry Demonstrates Abnormal Distribution of Gastrointestinal Stem Cells in Specialized and Non-Specialized Barrett's Mucosa. United States and Canadian Academy of Pathology 2011, 2/2011.
10. Gold KA, Lee JJ, Ping Y, Behrens C, Liu D, Lee H-Y, Koo JS, Lotan R, Soto LM, Rinsurongkawong, Stewart DJ, Lippman SM, Wistuba II, Hong WK, Kim ES, and Hofstetter WL. Biologic Risk Model for Recurrence in Resected Early Stage Non-Small Cell Lung Cancer (ES NSCLC). Present at The American Society of Clinical Oncology's 47th Annual Meeting, Chicago, Illinois, June 3-7, 2011. (#7053), 2011.
11. Kim JY, Correa AM, Swisher SG, Rice DC, Walsh GL, Vaporciyan AA, Mehran RJ, Bhutani M, Welsh J, Ajani J, Rohren E, and Hofstetter WL. Does the Timing of Esophagectomy After Neoadjuvant Chemoradiation Affect. Ann Thorac Surg (Presented at The Society of Thoracic Surgeons' 47th Annual Meeting, San Diego, California. January 30-February 2, 2011. 2011.
12. Suzuki A, Xiao L, Hayashi Y, Welsh J, Lin SH, Hofstetter W, Mehran RJ, Lee JH, Bhutani MS, Liao Z, and Ajani JA. Prognostic significance of post-treatment standardized uptake value (pSUV) of positron emission tomography (PET) to predict overall survival (OS) and relapse free survival (RFS) in patients with esophageal or gastroesophageal cancer treated with definitive chemoradiotherapy. Presented at The American Society of Clinical Oncology's 47th Annual Meeting, June 3-7, 2011, Chicago, Illinois, 2011.
13. Lin SH, Komaki R, Liao Z, Wei C, Cai H, Chang JY, Hofstetter WL, Swisher SG, Ajani J, and Cox JD. Proton Beam Therapy and Concurrent Chemotherapy for Esophageal Cancer. 2011 Poster Presentation, American Radium Society 2011 Annual Meeting, Palm Beach, Florida, April 30-May 4, 2011, 2011.
14. Blackmon SH, Correa AM, Chevray PM, Mehran R, Rice DC, Skoracki R, Vaporciyan AA, Walsh GL, Swisher SG, and Hofstetter WL. Super-Charged Jejunal Interposition for Esophageal Replacement: A 10 Year Experience. American College of Surgeons (#SP2011-14566), 2011.
15. Ajani JA, Wang X, Hayashi Y, Maru DM, Welsh J, Hofstetter WL, Lee JH, Bhutani MS, Suzuki A, Berry D, and Izzo J. Validated Biomarker Signatures That Predict Pathologic Response To Preoperative Chemoradiation Therapy (CTRT) With High Specificity and Desirable Sensitivity Levels In Patients With Esophageal Cancer (EC). American Society of Clinical Oncology, 2011.
16. Swisher SG, Hofstetter WL, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran RJ, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, and Ajani JA. Improved Long-term Outcome with Chemoradiotherapy Strategies in Esophageal Cancer. Ann Thorac Surg (56th STSA Annual Meeting, Marco Island, FL, 11/2009)) 90(3):892-8, 9/2010. PMID: 20732514.
17. Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, and Hofstetter WL. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status. Ann Thorac Surg (46th STS Annual Meeting, Fort Lauderdale, FL, 01/2010) 90(3):884-90, 9/2010. PMID: 20732513.
18. Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J Jr, Moran C, Vaporciyan AA, and Roth JA. Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg (46th STS Annual Meeting, Fort Lauderdale, FL, 01/2010 90(1):210-6, 7/2010. PMID: 20609777.
19. Gaur P, Hofstetter WL, Bekele BN, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, and Swisher SG. Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems. Ann Thorac Surg (56th STSA Annual Meeting, Marco Island, FL, 11/2009)) 89(6):1797-1803, 6/2010. PMID: 20494031.
20. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, Hofstetter WL, Marom EM, Mehran RJ, Vaporciyan AA, Walsh GL, and Swisher SG. Endoscopic Ultrasound-Guided Fine Needle. Ann Thorac Surg (45th STS Annual Meeting, San Francisco, CA 06/2009 88(3):832-8, 9/2009. PMID: 19699913.
21. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele N,. Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Rice DC, Walsh GL, Pisters KM, and Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg (88th Annual Meeting of The Amer. Assoc. for Thoracic Surg) 138(2):412-418.e1-2, 8/2009. e-Pub 5/2009. PMCID: PMC2731793.
22. Zhang Z, Chen Y, Chen Y, Jeter M, Hofstetter WL, Ajani J, Swisher SG, Chang JY, Allen PK, Cox JD, Komaki R, and Liao ZX. Outcomes with Esophageal Cancer Radiation Therapy. J Thorac Oncol (46th ASTRO Annual Meeting, Atlanta, GA, 2004) 4(7):880-888, 7/2009.
23. Hofstetter WL. Changes in cardiopulmonary reserves associated with neoadjuvant therapy in patients with esophageal cancer. J Clin Oncol (2009 ASCO Annual Meeting Proceedings) 27(15S) (#e15589), 6/2009.
24. Callender GG, Grubbs EG, Vu T, Hofstetter WL, Fleming JB, Woodburn KL, Lee JE, Evans DB, and Perrier ND. The fallen one: The inferior parathyroid gland that descends into the mediastinum. J Am Coll Surg (Presented at the Southern Surgical Association 120th Annual Meeting,West Palm Beach, FL, 12/2008) 208(5):887-93; discussion 893-5, 5/2009. PMID: 19476855.
25. Goodarzi M, Correa AM, Ajani JA, Swisher SG, Hofstetter WL, Guha S, Deavers MT, Rashid A, and Maru DM. Anti-phosphorylated histone H3 expression. Modern Pathology (U.S. and Canadian Academy of Path, Boston, MA, 03/2009), 2009.
26. Gaur P, Sepesi BA, Bhutani MS, Hofstetter WL, Correa AM, Ajani JA, Erasmus J, Komaki R, Lee JH, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Watson TJ, and Swisher SG. Endoscopic Esophageal Tumor Length (cL) Identifies Esophageal Cancer Patients with High Risk of Lymph Node Involvement and Poor Long-Term Survival: Internal and External Validation. American Surgical Association 2008, 11/2008.
27. Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RL. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol (Presented at the 12th World Conference on Lung Cancer, Seoul, South Korea, September 2-6, 2007) 3(9):979-84, 9/2008.
28. Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, and Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol (Presented at the United States and Canadian Academy of Pathology Annual Meeting, Denver CO, 2008) 32(9):1404-11, 9/2008. PMID: 18670347.
29. Vaporciyan AA, Bashkar S, Correa AM, Mendoza T, Hofstetter WL, Rice DC, Mehran RJ, Swisher SG, Wang XS, and Cleeland C. A novel system for measuring longitudinal postoperative symptom burden: proof of concept comparing VATS versus open lobectomy. The 88th Annual Meeting of the American Association for Thoracic Surgery. San Diego, California, 5/2008.
30. Fukami N, Dekovich AA, Hofstetter WL, Shah RJ, Sericati MR, Brauer BC, Sethi A, Khan AH, Chen YK. Frequency and risk factors of esophageal stricture after endoscopic mucosal resection (EMR) for Barrett’s esophagus with high-grade dysplasia (HGD) or adenocarcinoma (CA). American Society for Gastrointestinal Endoscopy (Oral or Poster, Digestive Disease Week 2008) (#CONTROL ID: 445546), 5/2008.
31. Bolton W, Hofstetter WL, Francis A, Correa AM, Ajani JA, Bhutani B, Erasmus J, Komaki R, Maru D, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, and Swisher SG. Impact of tumor length and submucosal involvement on the long-term survival of pT1 early stage esophageal adenocarcinoma. The 88th Annual Meeting of the American Association for Thoracic Surgery. San Diego, California, 5/2008.
32. Bolton W, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter WL, Komaki R, Mehran RJ, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, and Rhines L. Long-term survival with surgical management for superior sulcus tumors with vertebral resection. The 88th Annual Meeting of the American Association for Thoracic Surgery. San Diego, California, 5/2008.
33. Fukami N, Dekovich AA, Hofstetter WL. Multifocal high-grade dysplasia (MFHGD) in Barrett’s esophagus is associated with adenocarcinoma in patients undergoing endoscopic mucosal resection (EMR) for Barrett’s esophagus. Digestive Disease Week 2008, 5/2008.
34. Fukami N, Hofstetter WL, Maru DM, Dekovic AA. Multifocal high-grade dysplasia (MFHGD) in Barrett’s esophagus is associated with adenocarcinoma in patients undergoing endoscopic mucosal resection (EMR) for Barrett’s esophagus. GIE: Gastrointestinal Endoscopy (#445450), 5/2008.
35. Fukami N, Dekovich AA, Sericati MR, Maru D, Wang H, Hofstetter WL. Multifocal high-grade dysplasia (MFHGD) in Barrett's esophagus is associated with adenocarcinoma in patients undergoing endoscopic mucosal resection for Barrett's esophagus, 5/2008.
36. Hofstetter WL, Shah N, Lee J, Correa A, Ajani J, Erasmus J, Komaki R, Maru D, Mehran R, Rice D, Vaporciyan A, Walsh G, Bhutani M, Roth J, Swisher S. Salvage esophagectomy after concurrent chemotherapy and radiation: A Western experience. The 88th Annual Meeting of the American Association for Thoracic Surgery. San Diego, California, 5/2008.
37. Cen P, Ajani JA, Correa AM, Lee JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA. Adenocarcinoma of the lower esophagus with Barrett’s or without Barrett’s: differences in patients survival after preoperative chemoradiation (#4524), 2008.
38. Hofstetter W, Shah N, Lee J, Correa A, Ajani J, Erasmus J, Komaki R, Maru D, Mehran R, Rice D, Vaporciyan A, Walsh G, Bhutani M, Roth J, and Swisher S. Salvage esophagectomy after concurrent chemotherapy and radiation: A Western experience. American Association for Thoracic Surgery's 88th Annual Meeting, San Diego, California, May 10-15, 2008, 2008.
39. Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg (Presented at the Fifty-third Annual Meeting of the Southern Thoracic Surgical Association, Tucson, AZ, Nov 8–11, 2006) 84(5):1685-92, 11/2007.
40. Hofstetter WL, Correa AM, Ajani JA, Phan A, Komaki R, Liao Z, Wu T-T, Blackmon S, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, and Swisher SG. Proposed modifications of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg (Presented at the Fifty-third Annual Meeting of the Southern Thoracic Surgical Association, Tucson, AZ, Nov 8–11, 2006), 8/2007.
41. Blackmon SH, Correa AM, Wynn B, Martin LW, Hofstetter WL, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, and Vaporciyan AA. Propensity matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Ann Thorac Surg 83(5):1805-13; discussion 1813, 5/2007. PMID: 17462404.
42. Swisher SG, Winters K, Komaki R, Ajani J, Wu T.-T., Hofstetter WL, Konski A, and Willett C. A Phase II study of a Paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer. American Society for Therapeutic Radiology and Oncology, 2007.
43. Javeri HA, Arora R, Correa AM, Dixon DR, Komaki R, Hofstetter WL, Rice DC, Walsh GL, Vaporciyan AA, Swisher AG, Lee JH, Bhutani M, Ross WA, Liao Z, Maru DM, Dekovich AA, and Ajani JA. Comparison of the outcomes of patients with localized esophageal carcinoma receiving bimodal therapy versus trimodal therapy. International Society of Gastrointestinal Oncology (Poster presentation), 2007.
44. Blackmon SH, Rice DC, Correa AM, Hofstetter WL, Swisher SG, Mehran R, Vaporciyan AA, Walsh GL, and Roth JA. Does a gastrostomy tube versus jejunostomy tube prior to esophagectomy for primary esophageal cancer patients have additional risk?. Society of Thoracic Surgeons, 2007.
45. Rice DC, Correa AM, Hofstetter WL, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA, and Roth JA. Recent survival trends for clinically staged stage I lung cancer. Society of Thoracic Surgeons, 2007.
46. Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients. Ann Thorac Surg (Presented at the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 10–Feb 1, 2006) 82(6):1982-7, 12/2006.
47. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg (Read at the Eighty-fifth Annual Meeting of The American Association for Thoracic Surgery, San Francisco, Calif, April 10-13, 2005) 131(1):65-72, 1/2006.
48. Liu H, Blackmon S, Gayed I, MD, Wang X, Wei X, Tucker S, Liao Z, Hofstetter WL, Swisher SG, Mohan R, and Komaki R. Cardiac toxicity from chemoradiation with or without surgery in esophageal cancer patients. American Society for Therapeutic Radiology and Oncology, 2006.
49. Rice DC, Stevens C, Forster K, Vaporciyan AA, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, and Smythe WR. Survival and recurrence patterns following extrapleural pneumonectomy and intensity modulated radiation therapy for malignant pleural mesothelioma. Southern Thoracic Surgical Association, 2006.
50. Rice DC, Vaporciyan AA, Stevens C, Wu J, Walsh GL, Swisher SG, Hofstetter WL, Erasmus J, and Smythe WR. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg (Presented at the Forty-first Annual Meeting of The Society of Thoracic Surgeons, Tampa, FL, Jan 24–26, 2005) 80(6):1988-92, 12/2005.
51. Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg (Read at the Eighty-fifth Annual Meeting of The American Association for Thoracic Surgery, San Francisco, Calif, April 10-13, 2005) 130(6):1601-10, 12/2005.
52. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe RJ, and Walsh GL. Long segment supercharged pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 98(5):1391-8 (#18), 11/2005. e-Pub 10/2005. PMID: 16256794.
53. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. EUS-Identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in patients with adenocarcinoma of the distal esophagus. American Association for Thoracic Surgery's 85th Annual Meeting. San Francisco, California:102-103 (#20), 2005.
54. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, and Wu T-T. Number of lymph nodes with metastasis predict survival in patients with esophageal or esophagastric junction adenocarcinoma treated with preoperative chemoradiation. American Society of Clinical Oncology Annual Meeting, 2005.
55. Martin LW, Correa AM, Dolormente M, Francisco R, Martin F, Sarabia AJ, Hong WK, Smythe RW, Putnam JB, Hofstetter WL, Rice DC, Vaporciyan AA, Swisher SG, Walsh GL, Roth JA. Outcomes for resected stage IIIA Non-Small Cell Lung Cancer over 15 years at a single institution. American Association for Thoracic Surgery's 85th Annual Meeting. San Francisco, California:72-73 (#5), 2005.
56. Malaisrie SC, Hofstetter WL, Correa AM, Ajani, JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, and Swisher SG. The addition of induction chemotherapy to preoperative concurrent chemoradiotherapy improves tumor responses in patients with esophageal carcinoma. Western Surgical Thoracic Assocation's 31st Annual Meeting. Victoria, BC:34 (#3), 2005.
57. Hofstetter WL and Swisher SG. Lymph node dissection in esophageal cancer. In. S. C., Yang, and D. E. Cameron, (eds.). Current therapies in thoracic and cardiovascular surgery. Mosby, Inc., Philadelphia, Pennsylvania:360-363, 2004.
58. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Treatment outcomes of resected esophageal cancer. Ann Surg (Presented at the 122nd Annual Meeting of the American Surgical Association, April 24–27, 2002, The Homestead, Hot Springs, Virginia) 236(3):376-84, 9/2002.
59. Swisher SG, Hofstetter WL, Correa AM, Putnam JB Jr, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, and Roth JA. Evolving treatment outcomes of resected esophageal cancer over three decades for 951 patients at a single institution. American Surgical Association's 122nd Annual Meeting. Hot Springs, Virginia, 2002.
60. Hofstetter WL, Peters JH, DeMeester TR, Hagen JA, DeMeester SR, Crookes PF, Tsai P, Banki F, Bremner CG. Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg (Presented at the 121st Annual Meeting of the American Surgical Association April 26–28, 2001, the Broadmoor Hotel, Colorado Springs, Colorado) 234(4):532-8, 10/2001.
61. Hofstetter W, Ortega A, Chiang M, Brown B, Paik P, Youn P, Beart RW. Abdominal insufflation does not cause hematogenous spread of colon cancer. J Laparoendosc Adv Surg Tech A (Presented at the Annual Meeting of the American Society of Colon and REctal Surgeons, 1998) 10(1):1-4, 2/2000.
62. Sucharita Cheedella, Akihiro Suzuki, Arlene M. Correa, Wayne L. Hofstetter, Reza J. Mehran, David C. Rice, Dipen M. Maru, Ara A. Vaporciyan, Takashi Taketa, Mariela A. Blum, James Welsh, Steven H. Lin, Jaffrey H. Lee, Manoop S. Bhutani, Brian Weston, Garrett L. Walsh, Stephen G. Swisher, and Jaffer A. Ajani. Association of Clinical Complete Response (cCR) after Preoperative chemoradiation and Pathological Complete Response (pathCR) in patients with gastroesophageal cancer (GEC) and Indispensability of trimodality therapy (TMT). American Society of Clinical Oncology. Submitted.
63. Wolf DS, Ross WA, Ajani JA, Hofstetter WL, Swisher SG, Anandasabapathy S, Erasmus J, and Lee JH. Diagnostic Accuracy of eEndoscopic ultrasound (EUS) and management of T1 (T1a and T1b) esophageal cancer (EC). Digestive Disease Week 2009. Submitted.
64. Traves D. Crabtree, Varun Puri, William Burfeind, Andrzej Kosinski, Ankit Bharat, G Alexander Patterson, Wayne Hofstetter, Bryan F. Meyers. Evaluation of the Reliability of Clinical Staging of T2N0 Esophageal Cancer: A Review of the STS Database. Society of Thoracic Surgerons. Submitted.
65. David EA, Parsons AM, Correa AM, Steliga MA, Erasmus JJ, Hofstetter W, Kalhor N, Kim E, Lee PC, Mehran, Port JL, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Altorki NK and Swisher SG. Factors associated with Lymph Node Metastases in Clinically Node-Negative Non-Small Cell Lung Cancer. American Surgical Association. Submitted.
66. Wistuba II, Nunez MI, Behrens C, Woods DM, Lin H, Suraokar MB, Kadara HN, Minna J, Hirsch F, Hofstetter WL, Kalhor N, Hong WK, Lee JJ, Franklin W, Stewart DJ. High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and EGFR Mutation. Cancer Epidemiology, Biomarkers & Prevention. Submitted.
67. Muldoon TJ, Richards-Kortum R, Anandasabapathy S, and Hofstetter WL. High-resolution microendoscopy and image analysis for early cancer detection in gastrointestinal epithelium. Digestive Disease Week 2009. Submitted.
68. Betancourt S, Truong M, Palacio D, Moran C, Hofstetter W, Benveniste M, Godoy M, Marom E. Imaging, Staging, Evaluation and Treatment Consideration in Primary Salivary Gland-Type Lung Cancer (#1664). Submitted.
69. Heath D. Skinner, Matthew R. McCurdy, Alfredo E. Echeverria, Steven H. Lin, James W. Welsh, Michael S. O’Reilly, Wayne L. Hofstetter, Jaffer A. Ajani, Ritsuko Komaki, James D. Cox, Vlad C. Sandulache, Jeffrey N. Myers, Thomas M. Guerrero. Metformin use and improved response to therapy in esophageal adenocarcinoma. Acta Oncologica. Submitted.
70. Hofstetter WL, Correa AM, Lee JR, Ajani JA, Maru DM, Komaki R, Anandasabapathy S, Erasmus J, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, and Swisher SG. Predicting early postoperative outcomes after combined chemoradiotherapy for esophageal cancer using a nomogram. The American Association for Thoracic Surgery 89th Annual Meeting. Submitted.

Book Chapters
1. Hofstetter WL. Multimodality Treatment for Potentially Resectable Esophageal Cancer. In: Shackelford’s Surgery of the Alimentary Tract, Seventh Edition. Elsevier. In Press.
2. Bruzzi J, Marom EM, Hofstetter WL, McAleer MF. Esophageal Cancer. In: Oncologic Imagain A Multidisciplinary Approach. Elsevier Saunders, 211-230, 2012.
3. Bruzzi J, Marom E, Hofstetter W, McAleer M. Esophageal Cancer. In: Oncologic Imaging: A Multidisciplinary Approach. Saunders Elsevier, 2010.
4. Hofstetter WL. Salvage Esophagectomy for Persistent Disease After Definitive Chemoradiotherapy. In: Difficult Decisions in Thoracic Surgery, 2010.
5. Kim JY, Hofstetter WL. Tumors of the Mediastinum and Chest Wall. In: Surg Clin North Am. 90, 5. Saunders: Philadelphia, 1019-1040, e-Book 2010. ISBN: 20955881.
6. Hofstetter W. Principles of surgical therapy. In: Esophageal Cancer: Principles and Practice. Demos Medical Publishing: New York, NY USA, 277-282, 2009.
7. Kim MP, Hofstetter WL. Tumors of the Diaphragm. In: Thoracic Surgery Clinics. 19, 4, 521-529, 2009.
8. Hofstetter W. Management options for Barrett's esophagus with dysplasia. In: Advanced Therapy in Surgical Oncology. BC Decker Inc: Lewiston, NY USA, 25-32, 2008.
9. Hofstetter W. Esophageal conduits and palliative procedures. In: Mastery of Cardiothoracic Surgery, Second. Lippincot Williams & Wilkins: Philadelphia, PA USA, 174-186, 2007.
10. Al-Refaie WB, Hofstetter WL. Multimodality treatment of esophageal cancer (Chapter 36). In: Surgery of the Alimentary Tract. I, Sixth Edition. Ed(s) Yeo CJ,. Saunders: Philadelphia, Pennsylvania, 499-512, 2007.
11. Hofstetter WL, Swisher SG. Lymph node dissection in esophageal cancer. In: Current Therapy in Thoracic and Cardiovascular Surgery. Ed(s) Yang, S and Cameron, D. Mosby: Philadelphia, Pennsylvania, 360-363, 2004.
12. Blackmon SH, Hofstetter WL, and Swisher SG. Long Segment Super-charged Jejunal Interposition. In: Master Techniques in General Surgery, Esophagus and Stomach. Lippincott Williams & Wilkins: Philadelphia. Submitted.

Letters to the Editor
1. Hofstetter WL, Swisher SG, and Ajani JA. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma (Author reply to Correspondence). Cancer 109:1449, 1/2007.
2. Hofstetter WL, Ly P, Anthone G, Ortega AE, Vukasin P, and Beart RW Jr. Prevalence and distribution of anorectal misdiagnoses. West J of Med 168:549, 1998.

Grant & Contract Support

Title: Study of MAGE-A3 in Esophageal Adenocarcinoma
Funding Source: GlaxoSmithKline
Role: Principal Investigator
Duration: 9/10/2008 - 9/30/2011

Last updated: 3/1/2013